Details for New Drug Application (NDA): 070270
✉ Email this page to a colleague
NDA 070270 describes NALIDIXIC ACID, which is a drug marketed by Sun Pharm Industries and Watson Labs and is included in six NDAs. Additional details are available on the NALIDIXIC ACID profile page.
The generic ingredient in NALIDIXIC ACID is nalidixic acid. There are two drug master file entries for this compound. Additional details are available on the nalidixic acid profile page.
The generic ingredient in NALIDIXIC ACID is nalidixic acid. There are two drug master file entries for this compound. Additional details are available on the nalidixic acid profile page.
Summary for 070270
| Tradename: | NALIDIXIC ACID |
| Applicant: | Sun Pharm Industries |
| Ingredient: | nalidixic acid |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070270
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Jun 29, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
